Fig. 1.
Representative MRM chromatograms of (A) double blank plasma (without asenapine and asenapine13C-d3), (B) blank plasma spiked with asenapine13C-d3 (25.0 ng/mL), (C) asenapine (0.050 ng/mL), N-desmethyl asenapine (20.0 ng/mL) and asenapine-N-glucuronide (20.0 ng/mL) and asenapine13C-d3 (25 ng/mL), (D) asenapine (20.0 ng/mL), N-desmethyl asenapine (20.0 ng/mL) and asenapine-N-glucuronide (20.0 ng/mL) and asenapine13C-d3 (25 ng/mL) and (E) real subject sample at Cmax after oral administration of 10 mg dose of asenapine.